These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8818517)

  • 1. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models.
    Curr Opin Lipidol; 1996 Jun; 7(3):B23-36. PubMed ID: 8818517
    [No Abstract]   [Full Text] [Related]  

  • 2. Foxa2, a novel transcriptional regulator of insulin sensitivity.
    Puigserver P; Rodgers JT
    Nat Med; 2006 Jan; 12(1):38-9. PubMed ID: 16397559
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic predisposition in multiple metabolic syndrome. Part 3. Metabolism of lipids, lipoproteins and apolipoproteins].
    Sobra J; Ceska R
    Cas Lek Cesk; 1999 Mar; 138(5):136-41. PubMed ID: 10376396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
    den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, lipids, and adipocyte secretagogues.
    Faraj M; Lu HL; Cianflone K
    Biochem Cell Biol; 2004 Feb; 82(1):170-90. PubMed ID: 15052336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between insulin resistance and cholesteryl ester transfer protein gene polymorphism in type 2 diabetes mellitus].
    Jiang T; Song XX; Zhang M; Qi WH; Zhang XW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):298-301. PubMed ID: 15952120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of designed dietary fatty acid compositions on lipids in triacylglycerol-rich lipoproteins among Chinese patients with type 2 diabetes mellitus.
    Dai J; Su YX; Bartell S; Le NA; Ling WH; Liang YQ; Gao L; Wu HY; Veledar E; Vaccarino V
    Metabolism; 2009 Apr; 58(4):510-8. PubMed ID: 19303972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
    Dallinga-Thie GM; Dullaart RP; van Tol A
    Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism, exercise and insulin action.
    Bonen A; Dohm GL; van Loon LJ
    Essays Biochem; 2006; 42():47-59. PubMed ID: 17144879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate.
    Perret B; Ruidavets JB; Vieu C; Jaspard B; Cambou JP; Terce F; Collet X
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1134-40. PubMed ID: 12198387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
    Posadas-Sánchez R; Posadas-Romero C; Zamora-González J; Mendoza-Pérez E; Cardoso-Saldaña G; Yamamoto-Kimura L
    Metabolism; 2007 Dec; 56(12):1666-72. PubMed ID: 17998019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids in the heart: a source of fuel and a source of toxins.
    Park TS; Yamashita H; Blaner WS; Goldberg IJ
    Curr Opin Lipidol; 2007 Jun; 18(3):277-82. PubMed ID: 17495601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic model of fuel selection in the muscle.
    de Beaudrap P; Witten G; Biltz G; Perrier E
    J Theor Biol; 2006 Sep; 242(1):151-63. PubMed ID: 16574156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
    J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormalities in lipid metabolism associated with diabetes mellitus].
    Iizuka Y; Murase T; Iizuka Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():603-8. PubMed ID: 9392169
    [No Abstract]   [Full Text] [Related]  

  • 20. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
    Camejo G
    Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.